Tenecteplase Shortens Stroke Treatment and Transfer Times
🔓 Free Teaser Analysis Neurology / Neuropharmacology Confirmatory Grade: Low
Warach SJ, Weber JM, Alhanti B, et al.
Jul 13, 2026 · Published in: JAMA Network Open
Tenecteplase speeds up stroke thrombolysis compared to alteplase.
AAN and AHS Release Updated Adult Migraine Prevention Pharmacotherapy Guideline
Guideline Neurology / Neuropharmacology Practice-changing Grade: Moderate
Aug 31, 2026 · Published in: Neurology
New guidelines optimize migraine prevention with personalized strategies.
Marine-Derived Drugs in Alzheimer's: Modest, Inconsistent Cognitive Signals
Analysis Neurology / Neuropharmacology Hypothesis-generating Grade: Low
Song Z, Xie Y, Zhu H, et al.
Aug 10, 2026 · Published in: Therapeutic Advances in Neurological Disorders
Marine-derived drugs show potential but varied cognitive effects in Alzheimer's.
Perampanel and levetiracetam both control SeLECTS with minor sleep differences
Analysis Neurology / Neuropharmacology Hypothesis-generating Grade: Very Low
Yan L, Xie L, Li T, et al.
Aug 8, 2026 · Published in: Epilepsy & Behavior : E&B
PER may enhance sleep in children with SeLECTS.
Real-world lecanemab in Chinese patients: low ARIA, financial-driven discontinuation
Analysis Neurology / Neuropharmacology Hypothesis-generating Grade: Low
Wu H, Chen Q, Fang M, et al.
Aug 6, 2026 · Published in: Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Lecanemab shows safety but no cognitive boost in real-world AD study.
Extension Data Bolster Case Against Amyloid Therapy Coverage Restrictions
Analysis Neurology / Neuropharmacology Confirmatory Grade: Low
Boustani M, Klein EG, Zimmer JA, et al.
Aug 5, 2026 · Published in: Alzheimer's & Dementia
Amyloid therapies show promise in Alzheimer's treatment.
Cladribine tablets sustain remission through two treatment-free years
Analysis Neurology / Neuropharmacology Confirmatory Grade: Low
De Stefano N, Vermersch P, Wiendl H, et al.
Aug 4, 2026 · Published in: Multiple Sclerosis (Houndmills, Basingstoke, England)
Cladribine tablets show promise for sustained treatment-free remission in RMS.
Prior IV thrombolysis does not dictate first-line thrombectomy technique
Analysis Neurology / Neuropharmacology Confirmatory Grade: Low
Mouyal SJ, Maïer B, Labreuche J, et al.
Jul 24, 2026 · Published in: European Stroke Journal
Does prior thrombolysis influence thrombectomy effectiveness in stroke recovery?
Nanocarrier Delivery Systems for Overcoming Epilepsy Treatment Barriers
Analysis Neurology / Neuropharmacology Hypothesis-generating Grade: Very Low
Chauhan A, Kumar A, Awasthi A, et al.
Jul 23, 2026 · Published in: The Journal of Pharmacy and Pharmacology
Nanocarriers show potential for improving epilepsy drug delivery.
Low-Dose Thrombolysis Plus Argatroban Signals Benefit in Ischemic Stroke
Analysis Neurology / Neuropharmacology Hypothesis-generating Grade: Very Low
Huang S, Wang X, Li D, et al.
Jul 18, 2026 · Published in: Medicine
Combining tenecteplase with argatroban might enhance stroke recovery.
D-Dimer/Fibrinogen Ratio Predicts Poor Post-Thrombolysis Stroke Outcomes
Analysis Neurology / Neuropharmacology Hypothesis-generating Grade: Low
Zhang X, Fu Y, Lu J
Jul 11, 2026 · Published in: Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
New biomarker DFR predicts poor stroke outcomes post-thrombolysis.
Subcutaneous Natalizumab Cuts Chair Time, Cost, Boosts Quality of Life
Analysis Neurology / Neuropharmacology Confirmatory Grade: Low
Filippi M, Grimaldi LME, Brescia Morra V, et al.
Jul 10, 2026 · Published in: Journal of Neurology
Subcutaneous natalizumab streamlines MS care while enhancing patient experience.
Undiluted IV Push Valproic Acid Shows Favorable Safety Across 5500 Doses
Analysis Neurology / Neuropharmacology Confirmatory Grade: Low
Rollins S, Radosevich JJ, Sammani N, et al.
Jul 10, 2026 · Published in: Journal of Neurology
Undiluted IV push valproic acid proves safe for rapid seizure treatment.
Subcutaneous Levodopa Infusion Cuts OFF Time in Real-World Parkinson Care
Analysis Neurology / Neuropharmacology Confirmatory Grade: Low
Ali A, Cheema WA, Shamoon M, et al.
Jul 7, 2026 · Published in: Medicine
New infusion therapy eases Parkinson's motor symptoms with tolerability challenges.
IV Thrombolysis Before Thrombectomy Improves Recanalization in Extended Window
Analysis Neurology / Neuropharmacology Confirmatory Grade: Low
Nicolini E, Ciacciarelli A, Pracucci G, et al.
Jul 2, 2026 · Published in: European Journal of Neurology
IVT pre-MT improves stroke recanalization success post-4.5 hours.